| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |